Berenberg Bank assumed coverage on shares of Craneware (LON:CRW - Get Free Report) in a research report issued on Wednesday, Marketbeat reports. The brokerage set a "buy" rating and a GBX 2,800 ($37.58) price target on the stock. Berenberg Bank's target price suggests a potential upside of 13.82% from the company's current price.
Separately, Shore Capital reiterated a "buy" rating on shares of Craneware in a research report on Thursday, May 8th.
Get Our Latest Stock Report on Craneware
Craneware Stock Performance
LON:CRW traded down GBX 20 ($0.27) during midday trading on Wednesday, reaching GBX 2,460 ($33.02). 31,352 shares of the company traded hands, compared to its average volume of 81,196. Craneware has a twelve month low of GBX 1,330 ($17.85) and a twelve month high of GBX 2,580 ($34.63). The firm has a market capitalization of £1.06 billion, a price-to-earnings ratio of 90.89 and a beta of 0.28. The company has a debt-to-equity ratio of 12.22, a current ratio of 0.63 and a quick ratio of 1.00. The company has a fifty day moving average price of GBX 2,128.04 and a 200 day moving average price of GBX 1,944.
Insider Transactions at Craneware
In other Craneware news, insider Will Whitehorn purchased 1,911 shares of Craneware stock in a transaction on Thursday, April 24th. The stock was bought at an average price of GBX 1,584 ($21.26) per share, for a total transaction of £30,270.24 ($40,631.19). Company insiders own 19.28% of the company's stock.
About Craneware
(
Get Free Report)
The Craneware Group, the market leader in automated value cycle solutions, including 340B management, collaborates with U.S. healthcare providers to plan, execute, and monitor operational and financial performance so they can continue to deliver quality care to their communities. Customers choose The Craneware Group's Trisus data and applications platform as their key to navigating the journey to financially sustainable value-based care.
Recommended Stories
Before you consider Craneware, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Craneware wasn't on the list.
While Craneware currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
